vs

Side-by-side financial comparison of Porch Group, Inc. (PRCH) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $121.1M, roughly 1.4× Porch Group, Inc.). Porch Group, Inc. runs the higher net margin — -3.9% vs -82.0%, a 78.1% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs -22.7%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs -11.5%).

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

PRCH vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.4× larger
PTCT
$164.7M
$121.1M
PRCH
Growing faster (revenue YoY)
PRCH
PRCH
+122.7% gap
PRCH
100.0%
-22.7%
PTCT
Higher net margin
PRCH
PRCH
78.1% more per $
PRCH
-3.9%
-82.0%
PTCT
Faster 2-yr revenue CAGR
PRCH
PRCH
Annualised
PRCH
26.4%
-11.5%
PTCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCH
PRCH
PTCT
PTCT
Revenue
$121.1M
$164.7M
Net Profit
$-4.7M
$-135.0M
Gross Margin
52.7%
Operating Margin
34.7%
-43.3%
Net Margin
-3.9%
-82.0%
Revenue YoY
100.0%
-22.7%
Net Profit YoY
2.0%
-104.8%
EPS (diluted)
$-0.04
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCH
PRCH
PTCT
PTCT
Q1 26
$121.1M
Q4 25
$112.3M
$164.7M
Q3 25
$115.1M
$211.0M
Q2 25
$107.0M
$178.9M
Q1 25
$84.5M
$1.2B
Q4 24
$75.3M
$213.2M
Q3 24
$77.7M
$196.8M
Q2 24
$75.9M
$186.7M
Net Profit
PRCH
PRCH
PTCT
PTCT
Q1 26
$-4.7M
Q4 25
$-3.5M
$-135.0M
Q3 25
$-10.9M
$15.9M
Q2 25
$2.6M
$-64.8M
Q1 25
$8.4M
$866.6M
Q4 24
$30.5M
$-65.9M
Q3 24
$14.4M
$-106.7M
Q2 24
$-64.3M
$-99.2M
Gross Margin
PRCH
PRCH
PTCT
PTCT
Q1 26
52.7%
Q4 25
99.5%
Q3 25
75.6%
Q2 25
70.9%
Q1 25
77.4%
Q4 24
Q3 24
79.4%
Q2 24
22.1%
Operating Margin
PRCH
PRCH
PTCT
PTCT
Q1 26
34.7%
Q4 25
14.7%
-43.3%
Q3 25
14.2%
1.4%
Q2 25
4.7%
-19.5%
Q1 25
-1.5%
82.5%
Q4 24
33.3%
-76.2%
Q3 24
-3.2%
-27.7%
Q2 24
-69.2%
-21.5%
Net Margin
PRCH
PRCH
PTCT
PTCT
Q1 26
-3.9%
Q4 25
-3.1%
-82.0%
Q3 25
-9.4%
7.5%
Q2 25
2.4%
-36.3%
Q1 25
9.9%
73.7%
Q4 24
40.5%
-30.9%
Q3 24
18.5%
-54.2%
Q2 24
-84.8%
-53.1%
EPS (diluted)
PRCH
PRCH
PTCT
PTCT
Q1 26
$-0.04
Q4 25
$0.00
$-1.63
Q3 25
$-0.10
$0.20
Q2 25
$0.00
$-0.83
Q1 25
$0.07
$10.04
Q4 24
$0.34
$-0.85
Q3 24
$0.12
$-1.39
Q2 24
$-0.65
$-1.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCH
PRCH
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$68.4M
$1.9B
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$26.3M
$-205.3M
Total Assets
$806.6M
$2.9B
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCH
PRCH
PTCT
PTCT
Q1 26
$68.4M
Q4 25
$57.3M
$1.9B
Q3 25
$85.0M
$1.7B
Q2 25
$79.8M
$2.0B
Q1 25
$70.4M
$2.0B
Q4 24
$191.7M
$1.1B
Q3 24
$238.6M
$1.0B
Q2 24
$308.4M
$1.1B
Total Debt
PRCH
PRCH
PTCT
PTCT
Q1 26
$391.3M
Q4 25
$392.8M
Q3 25
$387.1M
Q2 25
$394.1M
Q1 25
$409.2M
Q4 24
$403.9M
Q3 24
$399.0M
Q2 24
$436.8M
Stockholders' Equity
PRCH
PRCH
PTCT
PTCT
Q1 26
$26.3M
Q4 25
$-24.6M
$-205.3M
Q3 25
$-27.9M
$-155.8M
Q2 25
$-29.3M
$-206.5M
Q1 25
$-52.4M
$-185.8M
Q4 24
$-43.2M
$-1.1B
Q3 24
$-77.0M
$-1.1B
Q2 24
$-101.9M
$-980.2M
Total Assets
PRCH
PRCH
PTCT
PTCT
Q1 26
$806.6M
Q4 25
$797.4M
$2.9B
Q3 25
$787.7M
$2.6B
Q2 25
$770.7M
$2.6B
Q1 25
$802.3M
$2.7B
Q4 24
$814.0M
$1.7B
Q3 24
$867.3M
$1.8B
Q2 24
$876.1M
$1.9B
Debt / Equity
PRCH
PRCH
PTCT
PTCT
Q1 26
14.87×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCH
PRCH
PTCT
PTCT
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCH
PRCH
PTCT
PTCT
Q1 26
Q4 25
$1.2M
$-34.3M
Q3 25
$40.8M
$-66.3M
Q2 25
$35.6M
$-58.3M
Q1 25
$-11.2M
$870.1M
Q4 24
$-26.6M
$-30.0M
Q3 24
$12.4M
$-77.0M
Q2 24
$-26.0M
$-71.5M
Free Cash Flow
PRCH
PRCH
PTCT
PTCT
Q1 26
Q4 25
$1.1M
$-36.6M
Q3 25
$40.7M
$-69.7M
Q2 25
$35.4M
$-59.6M
Q1 25
$-11.2M
$868.4M
Q4 24
$-26.8M
$-33.8M
Q3 24
$12.2M
$-77.5M
Q2 24
$-26.0M
$-78.8M
FCF Margin
PRCH
PRCH
PTCT
PTCT
Q1 26
Q4 25
1.0%
-22.3%
Q3 25
35.4%
-33.1%
Q2 25
33.0%
-33.3%
Q1 25
-13.3%
73.8%
Q4 24
-35.6%
-15.8%
Q3 24
15.7%
-39.4%
Q2 24
-34.3%
-42.2%
Capex Intensity
PRCH
PRCH
PTCT
PTCT
Q1 26
Q4 25
0.1%
1.4%
Q3 25
0.1%
1.6%
Q2 25
0.2%
0.7%
Q1 25
0.1%
0.1%
Q4 24
0.3%
1.8%
Q3 24
0.3%
0.3%
Q2 24
0.1%
4.0%
Cash Conversion
PRCH
PRCH
PTCT
PTCT
Q1 26
Q4 25
Q3 25
-4.17×
Q2 25
13.79×
Q1 25
-1.33×
1.00×
Q4 24
-0.87×
Q3 24
0.86×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons